Navigation Links
MiMedx to Present at American Academy of Orthopaedic Surgeons Annual Meeting

KENNESAW, Ga., Jan. 25, 2012 /PRNewswire/ -- MiMedx Group, Inc. (OTCBB: MDXG), an integrated developer, manufacturer and marketer of patent protected regenerative biomaterials and bioimplants processed from human amniotic membrane, announced today that they will be attending the American Academy of Orthopaedic Surgeons (AAOS) annual meeting, February 8 through February 10, 2012. The AAOS 2012 annual meeting will be held at the Moscone Center in San Francisco, California. 

MiMedx will be presenting the Company's biomaterial platform technologies developed for use in soft tissue trauma, nerve repair, spinal applications and sports medicine. During the conference, MiMedx will be presenting HydroFix®, one its device technologies, and AmnioFix®, one of is tissue technologies, and highlighting the Company's offerings, AmnioFix® Injectable and AmnioFix® Wrap.

Throughout the conference, MiMedx plans to sponsor various meetings with physicians and scientists to discuss and demonstrate the benefits and potential of these offerings. MiMedx Group will be located in Booth 2309 at the Moscone Center. 

About the Company

MiMedx® is an integrated developer, manufacturer and marketer of patent protected regenerative biomaterial products and bioimplants processed from human amniotic membrane.  "Innovations in Regenerative Biomaterials" is the framework behind our mission to give physicians products and tissues to help the body heal itself. Our biomaterial platform technologies include the device technologies HydroFix® and CollaFix™, and our tissue technologies, AmnioFix® and EpiFix®. Our tissue technologies, processed from the human amniotic membrane, utilize our proprietary Purion™ process that was developed by our wholly-owned subsidiary, Surgical Biologics, to produce a safe, effective and minimally manipulated implant. Surgical Biologics is the leading supplier of amniotic tissue, having supplied over 60,000 implants to date to distributors and OEMs for application in the Ophthalmic, Orthopedics, Spine, Wound Care and Dental sectors of healthcare.

SOURCE MiMedx Group, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. MiMedx Group, Inc. Receives CE Certification for Its CollaFix™ Surgical Mesh CD
2. MiMedx Group Completes $5,000,000 Private Placement
3. MiMedx Group, Inc. to Present at the 6th Annual Canaccord Genuity Cardiovascular, Aesthetics and Metabolic Disorders Conference
4. MiMedx Groups Chairman, Parker H. "Pete" Petit, Is Inducted Into the National Academy of Engineering
5. MiMedx Group Announces Second Quarter 2011 Results
6. MiMedx Group, Inc. Announces Release Date for Second Quarter Results
7. MiMedx Group Completes $5,000,000 Private Placement
8. MiMedx Group, Inc. to Present at the Noble Financial Capital Markets Seventh Annual Equity Conference
9. MiMedx Group Announces First Quarter 2011 Results
10. MiMedx Group Announces 2010 Results
11. MiMedx Group, Inc. to Present at the 10th Annual Needham Healthcare Conference
Post Your Comments:
(Date:6/23/2016)... Seattle, WA (PRWEB) , ... June 23, 2016 ... ... technology, announces the release of its second eBook, “Clinical Trials Patient Recruitment and ... patient recruitment and retention in this eBook by providing practical tips, tools, and ...
(Date:6/23/2016)... June 23, 2016 /PRNewswire/ - FACIT has announced ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" ... commercialization of a portfolio of first-in-class WDR5 inhibitors ... such as WDR5 represent an exciting class of ... precision medicine for cancer patients. Substantial advances have ...
(Date:6/23/2016)... ... June 23, 2016 , ... Charm Sciences, Inc. ... test has received AOAC Research Institute approval 061601. , “This is another AOAC-RI ... stated Bob Salter, Vice President of Regulatory and Industrial Affairs. “The Peel Plate ...
(Date:6/23/2016)...   EpiBiome , a precision microbiome engineering company, ... financing from Silicon Valley Bank (SVB). The financing will ... its drug development efforts, as well as purchase additional ... has been an incredible strategic partner to us – ... would provide," said Dr. Aeron Tynes Hammack , ...
Breaking Biology Technology:
(Date:4/15/2016)... Research and Markets has announced ... 2016-2020,"  report to their offering.  , ... global gait biometrics market is expected to grow ... 2016-2020. Gait analysis generates multiple variables ... to compute factors that are not or cannot ...
(Date:3/31/2016)...  Genomics firm Nabsys has completed a financial  restructuring ... , M.D., who returned to the company in October ... team, including Chief Technology Officer, John Oliver , ... and Vice President of Software and Informatics, Michael ... Dr. Bready served as CEO of Nabsys from 2005-2014 ...
(Date:3/22/2016)... , PROVO and ... -- Newborn Screening Ontario (NSO), which operates the highest ... for molecular testing, and Tute Genomics and UNIConnect, leaders ... technology respectively, today announced the launch of a project ... sequencing (NGS) testing panel. NSO has ...
Breaking Biology News(10 mins):